234 related articles for article (PubMed ID: 35726216)
1. Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer.
Wang N; Gu Y; Li L; Chi J; Liu X; Xiong Y; Zhong C
J Inflamm Res; 2022; 15():3477-3499. PubMed ID: 35726216
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis.
Yang Y; Li Z; Zhong Q; Zhao L; Wang Y; Chi H
Gland Surg; 2022 May; 11(5):892-912. PubMed ID: 35694087
[TBL] [Abstract][Full Text] [Related]
3. Identification of Ten-Gene Related to Lipid Metabolism for Predicting Overall Survival of Breast Invasive Carcinoma.
Wang Z; Wang F
Contrast Media Mol Imaging; 2022; 2022():8348780. PubMed ID: 35919504
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic effect and targets of
Yuan J; Lin M; Yang S; Yin H; Ouyang S; Xie H; Tang H; Ou X; Zeng Z
Heliyon; 2024 May; 10(10):e31137. PubMed ID: 38778969
[TBL] [Abstract][Full Text] [Related]
5. Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis.
Chen H; Liu Y; Yin Z; Chen H; Wang Y; Qian Y
Cell Cycle; 2023 May; 22(9):1077-1100. PubMed ID: 36757135
[TBL] [Abstract][Full Text] [Related]
6. Exploration of prognostic genes and risk signature in breast cancer patients based on RNA binding proteins associated with ferroptosis.
Chen X; Yang C; Wang W; He X; Sun H; Lyu W; Zou K; Fang S; Dai Z; Dong H
Front Genet; 2023; 14():1025163. PubMed ID: 36911389
[No Abstract] [Full Text] [Related]
7. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy.
Cai Y; Lin J; Wang Z; Ma Y; Pan J; Liu Y; Zhao Z
Front Oncol; 2022; 12():1009921. PubMed ID: 36324578
[TBL] [Abstract][Full Text] [Related]
9. Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Breast Invasive Carcinoma.
Huang R; Li Z; Zhang J; Zeng Z; Zhang J; Li M; Wang S; Xian S; Xue Y; Chen X; Li J; Cheng W; Wang B; Yan P; Yang D; Huang Z
Front Oncol; 2020; 10():613333. PubMed ID: 33585235
[TBL] [Abstract][Full Text] [Related]
10. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
11. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
[TBL] [Abstract][Full Text] [Related]
12. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J
Front Immunol; 2022; 13():783495. PubMed ID: 35222371
[TBL] [Abstract][Full Text] [Related]
14. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
15. CD40LG as a Prognostic Molecular Marker Regulates Tumor Microenvironment Through Immune Process in Breast Cancer.
Yuan M; Pei J; Li R; Tian L; He X; Li Y
Int J Gen Med; 2021; 14():8833-8846. PubMed ID: 34858051
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma.
Liu X; Fang X; Lu L; Liu G
Front Genet; 2022; 13():996625. PubMed ID: 36568396
[No Abstract] [Full Text] [Related]
17. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
18. Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics.
Wang N; Gu Y; Chi J; Liu X; Xiong Y; Zhong C; Wang F; Wang X; Li L
Front Genet; 2021; 12():721873. PubMed ID: 34408776
[No Abstract] [Full Text] [Related]
19. Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.
Ye M; Li L; Liu D; Wang Q; Zhang Y; Zhang J
PeerJ; 2021; 9():e12276. PubMed ID: 34721975
[TBL] [Abstract][Full Text] [Related]
20. Constructing a novel prognostic signature of tumor driver genes for breast cancer.
Zhou L; Yi Y; Liu C; Chen Z
Am J Transl Res; 2022; 14(7):4515-4531. PubMed ID: 35958490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]